Gencurix Inc - Asset Resilience Ratio

Latest as of June 2025: 4.01%

Gencurix Inc (229000) has an Asset Resilience Ratio of 4.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gencurix Inc (229000) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩1.08 Billion

≈ $730.31K USD Cash + Short-term Investments

Total Assets

₩26.90 Billion

≈ $18.23 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Gencurix Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Gencurix Inc assets under control.

Liquid Assets Composition Over Time

This chart breaks down Gencurix Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 229000 current and long-term liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.08 Billion	4.01%
Total Liquid Assets	₩1.08 Billion	4.01%

Asset Resilience Insights

Limited Liquidity: Gencurix Inc maintains only 4.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Gencurix Inc Industry Peers by Asset Resilience Ratio

Compare Gencurix Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Green Cross Lab Cell Corporation KQ:144510	Diagnostics & Research	0.18%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Check-Cap Ltd F:7CC	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%

Annual Asset Resilience Ratio for Gencurix Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Gencurix Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.11%	₩4.54 Billion ≈ $3.08 Million	₩30.04 Billion ≈ $20.36 Million	-18.54pp
2023-12-31	33.65%	₩11.27 Billion ≈ $7.64 Million	₩33.50 Billion ≈ $22.70 Million	+17.65pp
2022-12-31	16.01%	₩5.96 Billion ≈ $4.04 Million	₩37.24 Billion ≈ $25.24 Million	-23.72pp
2021-12-31	39.73%	₩21.96 Billion ≈ $14.88 Million	₩55.29 Billion ≈ $37.47 Million	+30.93pp
2020-12-31	8.80%	₩5.63 Billion ≈ $3.81 Million	₩63.98 Billion ≈ $43.36 Million	-16.06pp
2019-12-31	24.85%	₩593.34 Million ≈ $402.10K	₩2.39 Billion ≈ $1.62 Million	-46.40pp
2018-12-31	71.25%	₩7.23 Billion ≈ $4.90 Million	₩10.14 Billion ≈ $6.87 Million	+9.81pp
2017-12-31	61.44%	₩4.52 Billion ≈ $3.07 Million	₩7.36 Billion ≈ $4.99 Million	-7.41pp
2016-12-31	68.85%	₩6.36 Billion ≈ $4.31 Million	₩9.23 Billion ≈ $6.26 Million	--

pp = percentage points

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$31.07 Million

₩45.85 Billion KRW

Market Cap Rank

#23735 Global

#1639 in Korea

Share Price

₩1957.00

Change (1 day)

+0.88%

52-Week Range

₩1400.00 - ₩5870.00

All Time High

₩23845.65